Page 39 - Nasdaq Regn News Today

HNP Capital LLC reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 2.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,142 shares of the biopharmaceutical company’s stock after selling 31 shares during the period. HNP Capital LLC’s holdings […]

Erste Group Bank reaffirmed their buy rating on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Get Rating) in a research report report published on Tuesday morning, Benzinga reports. REGN has been the topic of several other reports. Jefferies Financial Group raised Regeneron Pharmaceuticals from a hold rating to a buy rating and boosted their price target […]

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) CFO Robert E. Landry sold 183 shares of the stock in a transaction on Monday, March 27th. The shares were sold at an average price of $821.70, for a total transaction of $150,371.10. Following the transaction, the chief financial officer now directly owns 32,929 shares in the company, […]

JB Capital LLC purchased a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 325 shares of the biopharmaceutical company’s stock, valued at approximately $234,000. Other institutional investors also recently bought and sold […]

WealthOne LLC purchased a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) during the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 297 shares of the biopharmaceutical company’s stock, valued at approximately $214,000. Other hedge funds and other institutional investors also recently modified their holdings of the company. PGGM Investments bought a new […]

Louisiana State Employees Retirement System reduced its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 3.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,200 shares of the biopharmaceutical company’s stock after selling 500 shares during the quarter. Louisiana State […]

Eudaimonia Advisors LLC trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 4.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 899 shares of the biopharmaceutical company’s stock after selling 44 shares during the quarter. Eudaimonia Advisors LLC’s holdings […]

ARK Investment Management LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 7.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,053 shares of the biopharmaceutical company’s stock after selling 2,888 shares during the quarter. ARK Investment Management […]

Transcend Capital Advisors LLC boosted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 37.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 418 shares of the biopharmaceutical company’s stock after acquiring an additional […]

Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 50.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 60 shares of the biopharmaceutical company’s stock after selling 60 shares during the quarter. […]